TY  - GEN
AU  - Rangwala,Reshma
AU  - Leone,Robert
AU  - Chang,Yunyoung C
AU  - Fecher,Leslie A
AU  - Schuchter,Lynn M
AU  - Kramer,Amy
AU  - Tan,Kay-See
AU  - Heitjan,Daniel F
AU  - Rodgers,Glenda
AU  - Gallagher,Maryann
AU  - Piao,Shengfu
AU  - Troxel,Andrea B
AU  - Evans,Tracey L
AU  - DeMichele,Angela M
AU  - Nathanson,Katherine L
AU  - O'Dwyer,Peter J
AU  - Kaiser,Jonathon
AU  - Pontiggia,Laura
AU  - Davis,Lisa E
AU  - Amaravadi,Ravi K
TI  - Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
SN  - 1554-8635
PY  - 2015///0330
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Autophagy
KW  - drug effects
KW  - Dacarbazine
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Hydroxychloroquine
KW  - Male
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Neoplasms
KW  - Temozolomide
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.4161/auto.29118
ER  -